B-lymphocyte antigen CD22 is a member of the recently described sialoadhesin family of immunoglobulin-like cell-surface glycoproteins that bind glycoconjugates terminating in sialic acid. One prominent ligand for CD22 is the highly glycosylated leukocyte surface protein CD45. Using surface plasmon resonance spectroscopy, we characterized the interaction of recombinant mouse CD22 with native CD45 purified from rat thymus (CD45-thy). By in situ desialylation and resialylation of immobilized CD45-thy, we show that mouse CD22 binds to the sialoglycoconjugate NeuGc2-6Gal1-4GlcNAc carried on CD45-thy N-glycans. Previous studies have shown that the sialic acid-binding site lies within the two membrane-distal domains of CD22 (domains 1 and 2), which are V-set and C2-set immunoglobulin superfamily domains, respectively. To further localize the binding site, we have made 42 single amino acid substitutions throughout both domains. All 12 mutations that abrogated binding to CD45-thy without disrupting antibody binding were of residues within the GFCC`C" -sheet of domain 1. These residues are predicted to form a contiguous binding site centered around an arginine residue in the F strand that is conserved in all members of the sialoadhesin family. Our results provide further evidence that immunoglobulin superfamily cell adhesion molecules use the GFCC`C" -sheet of membrane-distal V-set domains to bind structurally diverse ligands, suggesting that this surface is favored for cell-cell recognition.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Wang, I. Shiratori, T. Satoh, L. L. Lanier, and H. Arase An Essential Role of Sialylated O-Linked Sugar Chains in the Recognition of Mouse CD99 by Paired Ig-Like Type 2 Receptor (PILR) J. Immunol., February 1, 2008; 180(3): 1686 - 1693. [Abstract] [Full Text] [PDF]

				N. Kimura, K. Ohmori, K. Miyazaki, M. Izawa, Y. Matsuzaki, Y. Yasuda, H. Takematsu, Y. Kozutsumi, A. Moriyama, and R. Kannagi Human B-lymphocytes Express {alpha}2-6-Sialylated 6-Sulfo-N-acetyllactosamine Serving as a Preferred Ligand for CD22/Siglec-2 J. Biol. Chem., November 2, 2007; 282(44): 32200 - 32207. [Abstract] [Full Text] [PDF]

				B. E. Collins, O. Blixt, S. Han, B. Duong, H. Li, J. K. Nathan, N. Bovin, and J. C. Paulson High-Affinity Ligand Probes of CD22 Overcome the Threshold Set by cis Ligands to Allow for Binding, Endocytosis, and Killing of B Cells. J. Immunol., September 1, 2006; 177(5): 2994 - 3003. [Abstract] [Full Text] [PDF]

				A. Varki and T. Angata Siglecs--the major subfamily of I-type lectins Glycobiology, January 1, 2006; 16(1): 1R - 27R. [Abstract] [Full Text] [PDF]

				L. Nitschke, F. Lajaunias, T. Moll, L. Ho, E. Martinez-Soria, S. Kikuchi, M.-L. Santiago-Raber, C. Dix, R. M. E. Parkhouse, and S. Izui Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding Int. Immunol., January 1, 2006; 18(1): 59 - 68. [Abstract] [Full Text] [PDF]

				M. Zhang and A. Varki Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis Glycobiology, November 1, 2004; 14(11): 939 - 949. [Abstract] [Full Text] [PDF]

				C.-P. Danzer, B. E. Collins, O. Blixt, J. C. Paulson, and L. Nitschke Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling Int. Immunol., October 1, 2003; 15(10): 1137 - 1147. [Abstract] [Full Text] [PDF]

				S. Ogilvy, C. Louis-Dit-Sully, J. Cooper, R. L. Cassady, D. R. Alexander, and N. Holmes Either of the CD45RB and CD45RO Isoforms Are Effective in Restoring T Cell, But Not B Cell, Development and Function in CD45-Null Mice J. Immunol., August 15, 2003; 171(4): 1792 - 1800. [Abstract] [Full Text] [PDF]

				T. Angata, S. C. Kerr, D. R. Greaves, N. M. Varki, P. R. Crocker, and A. Varki Cloning and Characterization of Human Siglec-11. A RECENTLY EVOLVED SIGNALING MOLECULE THAT CAN INTERACT WITH SHP-1 AND SHP-2 AND IS EXPRESSED BY TISSUE MACROPHAGES, INCLUDING BRAIN MICROGLIA J. Biol. Chem., June 28, 2002; 277(27): 24466 - 24474. [Abstract] [Full Text] [PDF]

				F. Lajaunias, L. Nitschke, T. Moll, E. Martinez-Soria, I. Semac, Y. Chicheportiche, R. M. E. Parkhouse, and S. Izui Differentially Regulated Expression and Function of CD22 in Activated B-1 and B-2 Lymphocytes J. Immunol., June 15, 2002; 168(12): 6078 - 6083. [Abstract] [Full Text] [PDF]

				T. Angata, N. M. Varki, and A. Varki A Second Uniquely Human Mutation Affecting Sialic Acid Biology J. Biol. Chem., October 19, 2001; 276(43): 40282 - 40287. [Abstract] [Full Text] [PDF]

				T. K. van den Berg, D. Nath, H. J. Ziltener, D. Vestweber, M. Fukuda, I. van Die, and P. R. Crocker Cutting Edge: CD43 Functions as a T Cell Counterreceptor for the Macrophage Adhesion Receptor Sialoadhesin (Siglec-1) J. Immunol., March 15, 2001; 166(6): 3637 - 3640. [Abstract] [Full Text] [PDF]

				T. Angata and A. Varki Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily Glycobiology, April 1, 2000; 10(4): 431 - 438. [Abstract] [Full Text] [PDF]

				E. C. M. Brinkman-Van der Linden, E. R. Sjoberg, L. R. Juneja, P. R. Crocker, N. Varki, and A. Varki Loss of N-Glycolylneuraminic Acid in Human Evolution. IMPLICATIONS FOR SIALIC ACID RECOGNITION BY SIGLECS J. Biol. Chem., March 17, 2000; 275(12): 8633 - 8640. [Abstract] [Full Text] [PDF]

				H. Floyd, J. Ni, A. L. Cornish, Z. Zeng, D. Liu, K. C. Carter, J. Steel, and P. R. Crocker Siglec-8. A NOVEL EOSINOPHIL-SPECIFIC MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY J. Biol. Chem., January 14, 2000; 275(2): 861 - 866. [Abstract] [Full Text] [PDF]

				S. A. Wuensch, R. Y. Huang, J. Ewing, X. Liang, and J. T. Y. Lau Murine B cell differentiation is accompanied by programmed expression of multiple novel {beta}-galactoside {alpha}2,6-sialyltransferase mRNA forms Glycobiology, January 1, 2000; 10(1): 67 - 75. [Abstract] [Full Text] [PDF]

				G. Nicoll, J. Ni, D. Liu, P. Klenerman, J. Munday, S. Dubock, M.-G. Mattei, and P. R. Crocker Identification and Characterization of a Novel Siglec, Siglec-7, Expressed by Human Natural Killer Cells and Monocytes J. Biol. Chem., November 26, 1999; 274(48): 34089 - 34095. [Abstract] [Full Text] [PDF]

				M. K. Wild, A. Cambiaggi, M. H. Brown, E. A. Davies, H. Ohno, T. Saito, and P. A. van der Merwe Dependence of T Cell Antigen Recognition on the Dimensions of an Accessory Receptor–Ligand Complex J. Exp. Med., July 5, 1999; 190(1): 31 - 42. [Abstract] [Full Text] [PDF]

				L. Nitschke, H. Floyd, D. J.P. Ferguson, and P. R. Crocker Identification of CD22 Ligands on Bone Marrow Sinusoidal Endothelium Implicated in CD22-dependent Homing of Recirculating B Cells J. Exp. Med., May 3, 1999; 189(9): 1513 - 1518. [Abstract] [Full Text] [PDF]

				V. C. Taylor, C. D. Buckley, M. Douglas, A. J. Cody, D. L. Simmons, and S. D. Freeman The Myeloid-specific Sialic Acid-binding Receptor, CD33, Associates with the Protein-tyrosine Phosphatases, SHP-1 and SHP-2 J. Biol. Chem., April 23, 1999; 274(17): 11505 - 11512. [Abstract] [Full Text] [PDF]

				C. H. T. Chan, J. Wang, R. R. French, and M. J. Glennie Internalization of the Lymphocytic Surface Protein CD22 Is Controlled by a Novel Membrane Proximal Cytoplasmic Motif J. Biol. Chem., October 23, 1998; 273(43): 27809 - 27815. [Abstract] [Full Text] [PDF]

				A. L. Cornish, S. Freeman, G. Forbes, J. Ni, M. Zhang, M. Cepeda, R. Gentz, M. Augustus, K. C. Carter, and P. R. Crocker Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33 Blood, September 15, 1998; 92(6): 2123 - 2132. [Abstract] [Full Text] [PDF]

				E. D. Bell, A. P. May, and D. L. Simmons The Leukocyte Function-Associated Antigen-1 (LFA-1)-Binding Site on ICAM-3 Comprises Residues on Both Faces of the First Immunoglobulin Domain J. Immunol., August 1, 1998; 161(3): 1363 - 1370. [Abstract] [Full Text] [PDF]

				A. Irie, S. Koyama, Y. Kozutsumi, T. Kawasaki, and A. Suzuki The Molecular Basis for the Absence of N-Glycolylneuraminic Acid in Humans J. Biol. Chem., June 19, 1998; 273(25): 15866 - 15871. [Abstract] [Full Text] [PDF]

				C. Sato, K. Kitajima, S. Inoue, and Y. Inoue Identification of Oligo-N-glycolylneuraminic Acid Residues in Mammal-derived Glycoproteins by a Newly Developed Immunochemical Reagent and Biochemical Methods J. Biol. Chem., January 30, 1998; 273(5): 2575 - 2582. [Abstract] [Full Text] [PDF]

				S. Tang, Y. J. Shen, M. E. DeBellard, G. Mukhopadhyay, J. L. Salzer, P. R. Crocker, and M. T. Filbin Myelin-associated Glycoprotein Interacts with Neurons via a Sialic Acid Binding Site at ARG118 and a Distinct Neurite Inhibition Site J. Cell Biol., September 22, 1997; 138(6): 1355 - 1366. [Abstract] [Full Text] [PDF]

				B. E. Collins, M. Kiso, A. Hasegawa, M. B. Tropak, J. C. Roder, P. R. Crocker, and R. L. Schnaar Binding Specificities of the Sialoadhesin Family of I-type Lectins. SIALIC ACID LINKAGE AND SUBSTRUCTURE REQUIREMENTS FOR BINDING OF MYELIN-ASSOCIATED GLYCOPROTEIN, SCHWANN CELL MYELIN PROTEIN, AND SIALOADHESIN J. Biol. Chem., July 4, 1997; 272(27): 16889 - 16895. [Abstract] [Full Text] [PDF]

				M. Vinson, P. A. van der Merwe, Sør. Kelm, A. May, E. Y. Jones, and P. R. Crocker Characterization of the Sialic Acid-binding Site in Sialoadhesin by Site-directed Mutagenesis J. Biol. Chem., April 19, 1996; 271(16): 9267 - 9272. [Abstract] [Full Text] [PDF]

				T. Angata and A. Varki Cloning, Characterization, and Phylogenetic Analysis of Siglec-9, a New Member of the CD33-related Group of Siglecs. EVIDENCE FOR CO-EVOLUTION WITH SIALIC ACID SYNTHESIS PATHWAYS J. Biol. Chem., July 14, 2000; 275(29): 22127 - 22135. [Abstract] [Full Text] [PDF]

				S. M. W. van Rossenberg, L. A. J. M. Sliedregt, R. Autar, C. Piperi, A. P. Van der Merwe, T. J. C. van Berkel, J. Kuiper, and E. A. L. Biessen A Structure-Function Study of Ligand Recognition by CD22beta J. Biol. Chem., April 13, 2001; 276(16): 12967 - 12973. [Abstract] [Full Text] [PDF]

				M. Vinson, P. J. L. M. Strijbos, A. Rowles, L. Facci, S. E. Moore, D. L. Simmons, and F. S. Walsh Myelin-associated Glycoprotein Interacts with Ganglioside GT1b. A MECHANISM FOR NEURITE OUTGROWTH INHIBITION J. Biol. Chem., June 1, 2001; 276(23): 20280 - 20285. [Abstract] [Full Text] [PDF]

				N. Li, W. Zhang, T. Wan, J. Zhang, T. Chen, Y. Yu, J. Wang, and X. Cao Cloning and Characterization of Siglec-10, a Novel Sialic Acid Binding Member of the Ig Superfamily, from Human Dendritic Cells J. Biol. Chem., July 20, 2001; 276(30): 28106 - 28112. [Abstract] [Full Text] [PDF]

				Z. Yu, C.-M. Lai, M. Maoui, D. Banville, and S.-H. Shen Identification and Characterization of S2V, a Novel Putative Siglec That Contains Two V Set Ig-like Domains and Recruits Protein-tyrosine Phosphatases SHPs J. Biol. Chem., June 22, 2001; 276(26): 23816 - 23824. [Abstract] [Full Text] [PDF]

				M. K. Wild, M.-C. Huang, U. Schulze-Horsel, P. A. van der Merwe, and D. Vestweber Affinity, Kinetics, and Thermodynamics of E-selectin Binding to E-selectin Ligand-1 J. Biol. Chem., August 17, 2001; 276(34): 31602 - 31612. [Abstract] [Full Text] [PDF]

				T. Angata, R. Hingorani, N. M. Varki, and A. Varki Cloning and Characterization of a Novel Mouse Siglec, mSiglec-F. DIFFERENTIAL EVOLUTION OF THE MOUSE AND HUMAN (CD33) Siglec-3-RELATED GENE CLUSTERS J. Biol. Chem., November 21, 2001; 276(48): 45128 - 45136. [Abstract] [Full Text] [PDF]

				S. Kelm, J. Gerlach, R. Brossmer, C.-P. Danzer, and L. Nitschke The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound J. Exp. Med., May 6, 2002; 195(9): 1207 - 1213. [Abstract] [Full Text] [PDF]

				L. Jin, P. A. McLean, B. G. Neel, and H. H. Wortis Sialic Acid Binding Domains of CD22 Are Required For Negative Regulation of B Cell Receptor Signaling J. Exp. Med., May 6, 2002; 195(9): 1199 - 1205. [Abstract] [Full Text] [PDF]